TrialsNest
Sign Up
Research Sites

Decentralized trial activity checklist for research sites

A site checklist for decentralized trial activities covering visit ownership, local providers, home health, telehealth, data flow, and patient communication.

Research SitesUpdated 2026-06-214 min read

Decentralized trial activities need a location map, clear handoff ownership, completion evidence, and participant-facing instructions before remote or local-provider workflows begin.

Published Updated By TrialsNest editorial
Editorial review

How this resource is reviewed

Reviewed by TrialsNest clinical operations review on . These guides are written for operational education and updated when workflow, buyer, or trust boundaries change.

Editorial lens

How to use the tool without making it busywork

A useful decentralized trial activities should produce an owner, blocker, date, decision, or next action. If it only creates another document, the workflow still needs a sharper operating habit.

Completing the checklist away from the queue

The best review happens beside real work, where missing records, stale leads, and owner gaps are visible.

Leaving the result out of the next meeting

A checklist should feed the next coordinator, site, sponsor, or operations conversation.

Decision checklist

Before using it

Gather the current owner, status, blocker, source, and last meaningful movement.

While using it

Mark which answers need action instead of treating every item as equal.

After using it

Put the owner, due date, or reporting note back into the workflow.

What to keep in view

Decentralized trial operations should be mapped activity by activity, not treated as remote everything.
Sites should define scheduling, reminders, completion evidence, missed-step handling, and investigator review triggers for each decentralized element.
TrialsNest can help show decentralized activity status in the recruitment and visit-readiness workflow without replacing validated study source systems.

Operator questions

What item on this checklist would change today's queue?
Which answer needs a named owner or due date?
What should be reviewed again next week?

How teams usually use it

Compare it with the real queue

Read it next to the way your team already works. The gaps usually show up around ownership, missing records, follow-up timing, or sponsor-update prep.

Mark the handoffs

For each section, ask where the work changes hands. If the handoff depends on memory, a spreadsheet tab, or a buried message, that is probably worth fixing.

Keep the boundary clear

When the topic touches matching or prescreening, keep the language careful. Early fit is not enrollment, and final study decisions stay with authorized study teams.

Practical scenario

A practical use case

Use the checklist during a live recruitment review, then convert the answer into a queue update, sponsor note, source-quality decision, or follow-up task.

Before: the team agrees the issue matters but leaves without a visible owner.
After: the checklist creates a specific owner, blocker reason, and next review point.

Focused next reads for this topic

These links keep the page inside the same practical topic path instead of sending readers through broad navigation.

See it in TrialsNest

Turn this guide into a working recruitment workflow.

Walk through how patient intake, prescreening, records readiness, scheduling, and reporting connect in the product.

Decentralized does not mean undefined

The FDA describes decentralized elements as trial-related activities that occur away from traditional clinical trial sites, including telehealth visits, in-home visits, and visits with local health care providers.

That flexibility can reduce participant burden, but it creates operational risk when each activity does not have a clear owner, location, evidence path, and escalation rule.

A site should not wait until the first missed remote visit to decide who sends reminders, who confirms completion, and who reconciles documentation before investigator review.

Start with a location map

List every trial activity and assign where it happens: traditional site, participant home, telehealth visit, local provider office, lab partner, imaging partner, home health provider, device workflow, or app-based workflow.

Then identify the handoff attached to each activity. Who schedules it, who confirms it, what evidence returns to the site, what happens if the participant misses it, and what triggers investigator review?

The goal is a practical map that coordinators can use during daily work, not a long document that only exists in startup files. The map should also show how each activity affects recruitment status, visit readiness, and patient-facing next steps.

Use a case-study check

A site supports a hybrid study where some follow-up visits happen by telehealth and some labs occur locally. The first month looks efficient, but missed local labs increase because participants receive site visit reminders, not local lab instructions.

The site fixes the gap by creating location-specific reminders, adding local lab pending as a queue status, and assigning one coordinator to reconcile external lab completion before investigator review.

The protocol did not need a new promise. The workflow needed clearer location-specific ownership and completion evidence.

Add patient communication checks

Patient-facing instructions should explain which activities are remote, which require a site visit, which may happen with a local provider, and who to contact if technology, transportation, or scheduling fails.

Those instructions should be consistent with approved study materials. If the public recruitment page promises convenience that the protocol cannot support, the site may create confusion before screening ever begins.

Keep remote activity visible without overloading the queue

For recruitment and visit readiness, the useful status is often simple: remote visit pending, local lab needed, records received, scheduling-ready, investigator review pending, or missed activity follow-up needed.

TrialsNest can support that operating view by keeping decentralized activity status connected to owner, blocker, next action, and study context. It should not replace the study's validated source records or investigator oversight.

Site next step

Want this workflow organized in one place?

See how TrialsNest connects patient intake, prescreening, records readiness, coordinator follow-up, scheduling, and reporting for research sites.

Related TrialsNest workflows

These resource pages connect back to the product areas buyers usually ask about: public study search, site recruitment workflow, sponsor visibility, and the privacy-aware operating model.

Trust Center

Topics covered

decentralized trial activitiesremote clinical trial visitsdecentralized clinical trial checklisthybrid clinical trial operations

Common questions

What should teams know about decentralized trial activities?

Decentralized trial activities need a location map, clear handoff ownership, completion evidence, and participant-facing instructions before remote or local-provider workflows begin. The practical value is in connecting the concept to ownership, follow-up, records readiness, scheduling, reporting, and clear next actions.

Who is this resource written for?

This resource is written for research sites sorting through practical questions around decentralized trial activities and the workflow decisions that usually come with it.

Does this guide replace study-team review or medical advice?

No. TrialsNest resources are educational and operational. They do not provide medical advice, diagnosis, treatment, emergency care, or final clinical trial eligibility decisions.

How would a team use this workflow guidance in practice?

Use it to compare the current workflow with what actually happens day to day: where leads wait, where records get lost, where follow-up slows down, and what needs a clearer owner. The best next step is to turn the article takeaways into a short review checklist for decentralized trial activities.

Trust and proof points

Study-team decisions stay with authorized teams

TrialsNest can organize intake, prescreening, and workflow context, but it does not make final eligibility, enrollment, treatment, or medical decisions.

Reporting focuses on operational movement

Sponsor-ready updates should show source quality, movement, blockers, and next actions without becoming a broad patient-detail workspace.

Public pages stay educational

These resources explain clinical recruiting workflows and buying decisions. Sensitive study details belong in the appropriate secure workflow.

!
Heads up
Medical and eligibility decisions stay with the study team
TrialsNest does not provide medical advice, diagnosis, treatment, emergency care, or final study eligibility decisions. Authorized study teams review each protocol and applicant.

Continue exploring

Helpful next reads

Follow-up reading chosen from the same topic cluster and audience context as this guide.

Cookie preferences
Learn more about cookies

Essential cookies keep the site working. Optional cookies help improve traffic and regional insights.